Skip to main content

Table 2 The frequency and intensity of HPV16 E6 single peptide-specific T cell response

From: HPV16 E6-specific T cell response and HLA-A alleles are related to the prognosis of patients with cervical cancer

HPV16 E6 peptide Squamous cell carcinoma of cervix (n = 76)
Frequency (%) Mean magnitude (SFC/106)
E6 Peptide-1MHQKRTAMFQDPQERPRK1-18 6.58 39.80
E6 Peptide-2 FQDPQERPRKLPQLCTEL9-26 9.21 44.00
E6 Peptide-3 RKLPQLCTELQTTIHDII17-34 9.21 41.00
E6 Peptide-4 ELQTTIHDIILECVYCKQ25-42 10.53 41.62
E6 Peptide-5 IILECVYCKQQLLRREVY33-50 10.53 40.37
E6 Peptide-6 KQQLLRREVYDFAFRDLC41-58 6.58 45.20
E6 Peptide-7 VYDFAFRDLCIVYRDGNP49-66 9.21 45.85
E6 Peptide-8 LCIVYRDGNPYAVCDKCL57-74 9.21 46.14
E6 Peptide-9 NPYAVCDKCLKFYSKISE65-82 10.53 38.37
E6 Peptide-10 CLKFYSKISEYRHYCYSV73-90 19.74 40.20
E6 Peptide-11 SEYRHYCYSVYGTTLEQQ81-98 11.84 44.33
E6 Peptide-12 SVYGTTLEQQYNKPLCDL89-106 7.89 45.50
E6 Peptide-13 QQYNKPLCDLLIRCINCQ97-114 10.53 33.50
E6 Peptide-14 DLLIRCINCQKPLCPEEK105-122 19.74 44.20
E6 Peptide-15 CQKPLCPEEKQRHLDKKQ113-130 14.47 49.82
E6 Peptide-16 EKQRHLDKKQRFHNIRGR121-138 17.11 37.3
E6 Peptide-17 KQRFHNIRGRWTGRCMS129-146 17.11 47.84
E6 Peptide-18 GRWTGRCMSCCRSSRTRR137-154 10.53 44.37
  1. HPV, human papillomavirus